Practical Use of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Primary Care

Abstract

IN BRIEF The glucagon-like peptide-1 (GLP-1) receptor agonist class of medications has distinct benefits and limitations that provide an opportunity to individualize the treatment of patients with type 2 diabetes. Many strategies can be used to improve patient acceptance of and self-management with a GLP-1 receptor agonist.